do-me/EUR-LEX huggingface dataset:
WRITTEN QUESTION No. 3785/97 by Christof TANNERT to the Commission. Community aid to the Land of Berlin in 1996
Date: 1997-11-26
Institutions: European Parliament, TANNERT
Subjects: Berlin, EU aid, EU environmental policy, EU programme, EU research policy, European Regional Development Fund, European Social Fund, energy policy

8. 6. 98

EN

Official Journal of the European Communities

C 174/129

Because of the higher refund level for pure-bred breeding animals for heifers and cows compared with the lower
refund level for other female live animals, it is necessary to ensure through certain control measures that the
exported animals will not be slaughtered directly at arrival in the third country of destination.

The WTO agreement gives the possibility to differentiate the refund level. There is a higher refund level for
3.
pure-bred breeding animals than for cattle for slaughter. There is therefore no reason to ask for changes in the
rules at the next trade round.

(1)  OJ L 227, 11.8.1992.

(98/C 174/194)

WRITTEN QUESTION E-3784/97

by Carlos Pimenta (PPE) to the Commission

(26 November 1997)

Subject: Implementation of Council Proposal 97/C 207/11 for an Agreement on international humane trapping

standards between the European Community, Canada and the Russian Federation

If, as the Commission prefers, the Council decides to reject the opinion of the European Parliament and votes
instead to conclude the proposed Agreement with Canada and the Russian Federation, how does the Commission
propose to ensure that the terms of the Agreement will be implemented within the European Union?

In particular, does the Commission plan to bring forward a proposal for either a Directive or a Regulation and if
so, what will be the proposed legal basis?

Answer given by Sir Leon Brittan on behalf of the Commission

(21 January 1998)

The  Commission  would  point  out  to  the  Honourable  Member  that  the  Agreement  on  international  humane
trappings  standards  between  the  European  Community,  Canada  and  the  Russian  Federation  has  not  yet  been
ratified.

Even if the matter is already under consideration the Commission cannot make a formal statement on these issues
until the Agreement has been formally concluded by the Council. Parliament will be informed through the usual
channels if any proposal for incorporating this Agreement into Community law is adopted by the Commission.

(98/C 174/195)

WRITTEN QUESTION E-3785/97

by Christof Tannert (PSE) to the Commission

(26 November 1997)

Subject: Community aid to the Land of Berlin in 1996

What amounts of Community aid were approved and drawn for the Land of Berlin in 1996, for what measures
and under what programmes

1. 

2. 

3. 

4. 

5. 

6. 

in the European Regional Development Fund (ERDF)?

in the European Social Fund (ESF)?

in Community research programmes?

in Community programmes in the energy sector?

in Community programmes in the environmental sector?

in other of the Community(cid:146)s programmes?
WRITTEN QUESTION No. 3789/97 by David HALLAM to the Commission. Barrier to trade in Denmark: Veterinary pharmaceutical product, Super-Ov
Date: 1997-11-26
Institutions: European Parliament, HALLAM
Subjects: Denmark, United Kingdom, marketing restriction, pharmaceutical legislation, trade restriction, veterinary drug













EUR-Lex - 91997E3789 - EN






Avis juridique important




|



91997E3789

WRITTEN QUESTION No. 3789/97 by David HALLAM to the Commission. Barrier to trade in Denmark: Veterinary pharmaceutical product, Super-Ov  


Official Journal C 174 , 08/06/1998 P. 0131 





WRITTEN QUESTION E-3789/97 by David Hallam (PSE) to the Commission (26 November 1997)Subject: Barrier to trade in Denmark: Veterinary pharmaceutical product, Super-OvIs the Commission aware of the obstruction provided by the Danish authorities preventing Global Genetics of Unit One Moreton Farm, Eye, Leominster HR6 ODP from marketing the veterinary pharmaceutical product Super-Ov, for which the marketing authorization was applied for on 4 May 1994.What steps is the Commission taking to ensure that the Danish authorities comply with Directive 81/851/EEC ((OJ L 317, 6.11.1981, p. 1. )) and other single market compliance legislation?When does the Commission envisage this issue being resolved to the satisfaction of Global Genetics and the British authorities who have submitted a formal complaint on behalf of Global Genetics? (Complaint number 96/4399).Answer given by Mr Bangemann on behalf of the Commission (15 December 1997)The Honourable Member refers to a complaint lodged with the Commission concerning an alleged infringement of Community pharmaceutical legislation by Denmark. The complainant claimed that he had filed a complete application with the Danish authorities concerning the placing on the market of the veterinary medicinal product 'Super-OV' in May 1994 and that he had been waiting for a decision from the Danish authorities ever since.Following a request for information on this issue, the Danish authorities confirmed that they still needed additional information, in line with Community legislation, in order to be able to grant a marketing authorisation for the product in Denmark. On request of the Commission, the Danish authorities, on 25 October 1996, sent a letter to the complainant in which they listed the information and documentation which he still had to provide. The Commission advised the complainant several times to act accordingly and to provide the Danish authorities with the information and documentation legitimately required.As the complainant did not follow this advice, the Commission decided, on 15 October 1997, to close this complaint case.